249 related articles for article (PubMed ID: 23300914)
1. Structure of the TPR domain of AIP: lack of client protein interaction with the C-terminal α-7 helix of the TPR domain of AIP is sufficient for pituitary adenoma predisposition.
Morgan RM; Hernández-Ramírez LC; Trivellin G; Zhou L; Roe SM; Korbonits M; Prodromou C
PLoS One; 2012; 7(12):e53339. PubMed ID: 23300914
[TBL] [Abstract][Full Text] [Related]
2. AIP and its interacting partners.
Trivellin G; Korbonits M
J Endocrinol; 2011 Aug; 210(2):137-55. PubMed ID: 21454441
[TBL] [Abstract][Full Text] [Related]
3. Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients.
Cazabat L; Bouligand J; Salenave S; Bernier M; Gaillard S; Parker F; Young J; Guiochon-Mantel A; Chanson P
J Clin Endocrinol Metab; 2012 Apr; 97(4):E663-70. PubMed ID: 22319033
[TBL] [Abstract][Full Text] [Related]
4. Mutations of the gene for the aryl hydrocarbon receptor-interacting protein in pituitary adenomas.
Cazabat L; Guillaud-Bataille M; Bertherat J; Raffin-Sanson ML
Horm Res; 2009; 71(3):132-41. PubMed ID: 19188737
[TBL] [Abstract][Full Text] [Related]
5. Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications.
Jaffrain-Rea ML; Angelini M; Gargano D; Tichomirowa MA; Daly AF; Vanbellinghen JF; D'Innocenzo E; Barlier A; Giangaspero F; Esposito V; Ventura L; Arcella A; Theodoropoulou M; Naves LA; Fajardo C; Zacharieva S; Rohmer V; Brue T; Gulino A; Cantore G; Alesse E; Beckers A
Endocr Relat Cancer; 2009 Sep; 16(3):1029-43. PubMed ID: 19556287
[TBL] [Abstract][Full Text] [Related]
6. Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.
Beckers A; Aaltonen LA; Daly AF; Karhu A
Endocr Rev; 2013 Apr; 34(2):239-77. PubMed ID: 23371967
[TBL] [Abstract][Full Text] [Related]
7. The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas.
Leontiou CA; Gueorguiev M; van der Spuy J; Quinton R; Lolli F; Hassan S; Chahal HS; Igreja SC; Jordan S; Rowe J; Stolbrink M; Christian HC; Wray J; Bishop-Bailey D; Berney DM; Wass JA; Popovic V; Ribeiro-Oliveira A; Gadelha MR; Monson JP; Akker SA; Davis JR; Clayton RN; Yoshimoto K; Iwata T; Matsuno A; Eguchi K; Musat M; Flanagan D; Peters G; Bolger GB; Chapple JP; Frohman LA; Grossman AB; Korbonits M
J Clin Endocrinol Metab; 2008 Jun; 93(6):2390-401. PubMed ID: 18381572
[TBL] [Abstract][Full Text] [Related]
8. AIP mutations and gigantism.
Rostomyan L; Potorac I; Beckers P; Daly AF; Beckers A
Ann Endocrinol (Paris); 2017 Jun; 78(2):123-130. PubMed ID: 28483363
[TBL] [Abstract][Full Text] [Related]
9. AIP mutations impair AhR signaling in pituitary adenoma patients fibroblasts and in GH3 cells.
Lecoq AL; Viengchareun S; Hage M; Bouligand J; Young J; Boutron A; Zizzari P; Lombès M; Chanson P; Kamenický P
Endocr Relat Cancer; 2016 May; 23(5):433-43. PubMed ID: 27080473
[TBL] [Abstract][Full Text] [Related]
10. A novel C-terminal nonsense mutation, Q315X, of the aryl hydrocarbon receptor-interacting protein gene in a Japanese familial isolated pituitary adenoma family.
Iwata T; Yamada S; Ito J; Inoshita N; Mizusawa N; Ono S; Yoshimoto K
Endocr Pathol; 2014 Sep; 25(3):273-81. PubMed ID: 24789813
[TBL] [Abstract][Full Text] [Related]
11. Aryl Hydrocarbon Receptor-Interacting Protein (AIP) N-Terminus Gene Mutations Identified in Pituitary Adenoma Patients Alter Protein Stability and Function.
Formosa R; Vassallo J
Horm Cancer; 2017 Jun; 8(3):174-184. PubMed ID: 28255869
[TBL] [Abstract][Full Text] [Related]
12. Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations.
Georgitsi M; Raitila A; Karhu A; Tuppurainen K; Mäkinen MJ; Vierimaa O; Paschke R; Saeger W; van der Luijt RB; Sane T; Robledo M; De Menis E; Weil RJ; Wasik A; Zielinski G; Lucewicz O; Lubinski J; Launonen V; Vahteristo P; Aaltonen LA
Proc Natl Acad Sci U S A; 2007 Mar; 104(10):4101-5. PubMed ID: 17360484
[TBL] [Abstract][Full Text] [Related]
13. The FKBP-type domain of the human aryl hydrocarbon receptor-interacting protein reveals an unusual Hsp90 interaction.
Linnert M; Lin YJ; Manns A; Haupt K; Paschke AK; Fischer G; Weiwad M; Lücke C
Biochemistry; 2013 Mar; 52(12):2097-107. PubMed ID: 23418784
[TBL] [Abstract][Full Text] [Related]
14. Germline and mosaic mutations causing pituitary tumours: genetic and molecular aspects.
Pepe S; Korbonits M; Iacovazzo D
J Endocrinol; 2019 Feb; 240(2):R21-R45. PubMed ID: 30530903
[TBL] [Abstract][Full Text] [Related]
15. Aryl hydrocarbon receptor interacting protein (AIP) gene mutation analysis in children and adolescents with sporadic pituitary adenomas.
Georgitsi M; De Menis E; Cannavò S; Mäkinen MJ; Tuppurainen K; Pauletto P; Curtò L; Weil RJ; Paschke R; Zielinski G; Wasik A; Lubinski J; Vahteristo P; Karhu A; Aaltonen LA
Clin Endocrinol (Oxf); 2008 Oct; 69(4):621-7. PubMed ID: 18410548
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetics of the aip gene in familial pituitary tumorigenesis.
Tahir A; Chahal HS; Korbonits M
Prog Brain Res; 2010; 182():229-53. PubMed ID: 20541668
[TBL] [Abstract][Full Text] [Related]
17. The AIP (aryl hydrocarbon receptor-interacting protein) gene and its relation to the pathogenesis of pituitary adenomas.
Lloyd C; Grossman A
Endocrine; 2014 Aug; 46(3):387-96. PubMed ID: 24366639
[TBL] [Abstract][Full Text] [Related]
18. Isolated familial somatotropinoma: 11q13-loh and gene/protein expression analysis suggests a possible involvement of aip also in non-pituitary tumorigenesis.
Toledo RA; Mendonca BB; Fragoso MC; Soares IC; Almeida MQ; Moraes MB; Lourenço DM; Alves VA; Bronstein MD; Toledo SP
Clinics (Sao Paulo); 2010 Apr; 65(4):407-15. PubMed ID: 20454499
[TBL] [Abstract][Full Text] [Related]
19. A novel germline mutation in the aryl hydrocarbon receptor-interacting protein (AIP) gene in an Italian family with gigantism.
Urbani C; Russo D; Raggi F; Lombardi M; Sardella C; Scattina I; Lupi I; Manetti L; Tomisti L; Marcocci C; Martino E; Bogazzi F
J Endocrinol Invest; 2014 Oct; 37(10):949-55. PubMed ID: 24996936
[TBL] [Abstract][Full Text] [Related]
20. Risk category system to identify pituitary adenoma patients with
Caimari F; Hernández-Ramírez LC; Dang MN; Gabrovska P; Iacovazzo D; Stals K; Ellard S; Korbonits M;
J Med Genet; 2018 Apr; 55(4):254-260. PubMed ID: 29440248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
